Abstract:Background Hepatocellular carcinoma (HCC) is the second-highest cause of malignancy-related death worldwide, and many physiological and pathological processes, including cancer, are regulated by microRNAs (miRNAs). miR-193a-3p is an anti-oncogene that plays an important part in health and disease biology by interacting with specific targets and signals. Methods In vitro assays were performed to explore the influences of miR-193a-3p on the propagation and apoptosis of HCC cells. The sequencing data for HCC were obtained from The Cancer Genome Atlas (TCGA), and the expression levels of miR-193a-3p in HCC and non-HCC tissues were calculated. The differential expression of miR-193a-3p in HCC was presented as standardized mean difference (SMD) with 95% confidence intervals (CIs) in Stata SE. The impact of miR-193a-3p on the prognoses of HCC patients was determined by survival analysis. The potential targets of miR-193a-3p were then predicted using miRWalk 2.0 and subjected to enrichment analyses, including Gene Ontology (GO) annotation, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis, and Protein-Protein Interaction (PPI) network analysis. The interaction between miR-193a-3p and one predicted target, Cyclin D1 (CCND1), was verified by dual luciferase reporter assays and Pearson correlation analysis. Results MiR-193a-3p inhibited the propagation and facilitated the apoptosis of HCC cells in vitro. The pooled SMD indicated that miR-193a-3p had a low level of expression in HCC (SMD: −0.88, 95% CI [−2.36 −0.59]). Also, HCC patients with a higher level of miR-193a-3p expression tended to have a favorable overall survival (OS: HR = 0.7, 95% CI [0.43–1.13], P = 0.14). For the KEGG pathway analysis, the most related pathway was “proteoglycans in cancer”, while the most enriched GO term was “protein binding”. The dual luciferase reporter assays demonstrated the direct interaction between miR-193a-3p and CCND1, and the Pearson correlation analysis suggested that miR-193a-3p was negatively correlated with CCND1 in HCC tissues (R = − 0.154, P = 0.002). Conclusion miR-193a-3p could suppress proliferation and promote apoptosis by targeting CCND1 in HCC cells. Further, miR-193a-3p can be used as a promising biomarker for the diagnosis and treatment of HCC in the future.

Mir-125B-5p Inhibits Cell Proliferation, Migration, and Invasion in Hepatocellular Carcinoma Via Targeting TXNRD1.

MicroRNA‐122 Suppresses Cell Proliferation and Induces Cell Apoptosis in Hepatocellular Carcinoma by Directly Targeting Wnt/β‐catenin Pathway

MiR-148b Suppresses Cell Proliferation and Invasion in Hepatocellular Carcinoma by Targeting WNT1/β-catenin Pathway

Mir-125A-5p Inhibits Tumorigenesis in Hepatocellular Carcinoma.

Ectopic Expression Of Mir-125a Inhibits The Proliferation And Metastasis Of Hepatocellular Carcinoma By Targeting Mmp11 And Vegf

Mir-125b Suppresses The Proliferation Of Hepatocellular Carcinoma Cells By Targeting Sirtuin7

MiR-125b Attenuates Human Hepatocellular Carcinoma Malignancy Through Targeting SIRT6.

MicroRNA-125b Suppressesed Human Liver Cancer Cell Proliferation and Metastasis by Directly Targeting Oncogene LIN28B2

MiR-125b Loss Activated HIF1/pAKT Loop, Leading to Transarterial Chemoembolization Resistance in Hepatocellular Carcinoma

Upregulation of miR-1254 promotes Hepatocellular Carcinoma Cell Proliferation, Migration, and Invasion via Inactivation of the Hippo-YAP signaling pathway by decreasing PAX5

Down-regulation of Microrna-125B-2-3p is a Risk Factor for a Poor Prognosis in Hepatocellular Carcinoma

MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4.

Reduced Mir-125A Levels Associated with Poor Survival of Patients with Hepatocellular Cancer

MicroRNA Mir-124-3p Suppresses Proliferation and Epithelial–mesenchymal Transition of Hepatocellular Carcinoma Via ARRDC1 (arrestin Domain Containing 1)

MicroRNA-1251-5p Promotes Tumor Growth and Metastasis of Hepatocellular Carcinoma by Targeting AKAP12

MicroRNA-125b Induces Cancer Cell Apoptosis Through Suppression of Bcl-2 Expression.

Downregulation of Mir-193A-3p is Involved in the Pathogenesis of Hepatocellular Carcinoma by Targeting CCND1

Mir-125B is Methylated and Functions As a Tumor Suppressor by Regulating the ETS1 Proto-Oncogene in Human Invasive Breast Cancer.

MicroRNA-381 Suppresses Cell Growth and Invasion by Targeting the Liver Receptor Homolog-1 in Hepatocellular Carcinoma.

MiR-1254 Suppresses HO-1 Expression Through Seed Region-Dependent Silencing and Non-Seed Interaction with TFAP2A Transcript to Attenuate NSCLC Growth

MicroRNA‐125a‐5p regulates liver cancer cell growth, migration and invasion and EMT by targeting HAX1